The safety and efficiency of ultrasound-guided percutaneous transhepatic portal pressure gradient measurement for patients with portal hypertension in liver cirrhosis.

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041002

Enrollment

Unknown

Registered

2020-12-16

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal hypertesion in cirrhosis

Interventions

Gold Standard:HVPG/PPG measurement in TIPS

Index test:PPG&#32

measurement&#32

in&#32

ultrasound-guided&#32

transhepatic&#32

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 80 to 18 years; 2.Liver cirrhosis with portal hypertesion; 3.Liver cirrhosis with esophageal and gastric varices; 4.Liver cirrhosis with esophagogastric variceal hemorrhage. 5.Patients who sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Absolute contraindication:Unable to lie flat; unable to tolerate procedure; 2.Relative contraindications: 1)severe coagualtion dysfunction(INR > 1.6); 2)severe cardiac/pulmonary/kidney failure; 3)incooperate; 4)Extrahepatic biliary tract obstruction; 5)Biliary tract infection; 6)Uncorrectable abodominal ascites; 7)liver amyloidosis; 8)polycystic liver; 9)massive hepatic carcinoma.

Design outcomes

Primary

Measure	Time frame
portal pressure gradient;	—

Countries

China

Contacts

Public ContactWei Wu

The First Affiliated Hospital of Wenzhou Medical University

wwwwwuwei@126.com+86 13566290340

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026